Dr. Lee-Jah Chang is a Senior Director, Global Clinical Development, at Sanofi Pasteur. Currently, he is the Global Clinical Team Leader for the Quadrivalent High-Dose influenza and pandemic influenza vaccine programs and has previously worked on other vaccine programs including one for pneumococcus, meningococcus, and herpes simplex virus. Dr. Chang attended Northwestern University Feinberg School of Medicine and completed his Internal Medicine residency at Northwestern McGaw Medical Center in Chicago. After completing his Allergy and Immunology fellowship at the National Institutes of Health in Bethesda, Maryland, he joined Sanofi Pasteur and has been with the company since 2013. He is board certified in both Internal Medicine and Allergy and Immunology and a fellow of the American Academy of Allergy, Asthma, and Immunology.
Disclosure: Sanofi Pasteur (Individual(s) Involved: Self): Employee